Citation: | LI Qun, SHEN Jun, SHI Wanqing, LIN Ning, HOU Shiqiang. Prevalence and risk factors of Helicobacter pylori infection in the physical examination population in Chuzhou, Anhui Province[J]. Chinese Journal of General Practice, 2025, 23(5): 765-767. doi: 10.16766/j.cnki.issn.1674-4152.003996 |
[1] |
何昀, 黄为民, 刘志刚, 等. 佛山地区小学生幽门螺杆菌感染流行病学调查[J]. 河北医药, 2022, 44(3): 460-463.
HE Y, HUANG W M, LIU Z G, et al. The epidemiological investigation on the infection status of Helicobacter pylori in pupils in Foshan area[J]. Hebei Medical Journal, 2022, 44(3): 460-463.
|
[2] |
尚雨蒙, 柯希权, 褚正洋, 等. 伏诺拉生二联疗法在幽门螺杆菌根治中的效果观察[J]. 中华全科医学, 2024, 22(7): 1142-1145. doi: 10.16766/j.cnki.issn.1674-4152.003585
SHANG Y M, KE X Q, CHU Z Y, et al. Observation on the effect of Vonoprazan-based dual therapy in radical treatment of Helicobacter pylori[J]. Chinese Journal of General Practice, 2024, 22(7): 1142-1145. doi: 10.16766/j.cnki.issn.1674-4152.003585
|
[3] |
方颖, 金家东, 黄冬波, 等. 非酒精性脂肪性肝病与幽门螺杆菌感染关系的探讨[J]. 胃肠病学和肝病学杂志, 2024, 33(3): 261-264.
FANG Y, JIN J D, HUANG D B, et al. The relationship between non-alcoholic fatty liver disease and Helicobacter pylori infection[J]. Chinese Journal of Gastroenterology and Hepatology, 2024, 33(3): 261-264.
|
[4] |
周桃梅, 刘思宇, 戴木根. 血清胃蛋白酶原对持续幽门螺杆菌感染无症状患者的诊断价值[J]. 中华全科医学, 2024, 22(5): 772-775. doi: 10.16766/j.cnki.issn.1674-4152.003500
ZHOU T M, LIU S Y, DAI M G. Diagnostic performance of serum pepsinogen in asymptomatic patients with persistent Helicobacter pylori infection[J]. Chinese Journal of General Practice, 2024, 22(5): 772-775. doi: 10.16766/j.cnki.issn.1674-4152.003500
|
[5] |
苏娥, 夏啰啰, 钟丽, 等. 幽门螺杆菌感染患者致配偶感染的危险因素分析[J]. 重庆医学, 2021, 50(13): 2252-2255.
SU E, XIA L L, ZHONG L, et al. Analysis of risk factors for spouse infection caused by patients with Helicobacter pylori infection[J]. Chongqing Medicine, 2021, 50(13): 2252-2255.
|
[6] |
张彦亭, 杨振威, 原姗姗, 等. 不同分型幽门螺杆菌感染消化性溃疡患者血清胃蛋白酶原、共刺激分子CD40、α防御素表达及检测意义[J]. 陕西医学杂志, 2020, 49(10): 1310-1313.
ZHANG Y T, YANG Z W, YUAN S S, et al. Expression and significance of serum pepsinogen, costimulatory molecule CD40 and α defensin in patients with peptic ulcer infected by different types of Helicobacter pylori[J]. Shaanxi Medical Journal, 2020, 49(10): 1310-1313.
|
[7] |
阮奥, 候惠琳, 曹剑霞, 等. 13C-尿素呼气试验采用直接吹气与端口消毒法检测结果的对比分析[J]. 标记免疫分析与临床, 2023, 30(11): 1949-1953.
RUAN A, HOU H L, CAO J X, et al. The Value of Collection Port Disinfection for the Measurement Accuracyof H. Pylori Infection by 13C-urea Breath Test[J]. Labeled Immunoassays and Clinical Medicine, 2023, 30(11): 1949-1953.
|
[8] |
刘茜, 刘晓娜, 李超, 等. 不同方案治疗幽门螺杆菌感染合并小肠细菌过度生长的疗效分析[J]. 实用医学杂志, 2024, 40(9): 1303-1308.
LIU X, LIU X N, LI C, et al. Efficacy analysis of different regimens for treatment of Helicobacter pylori infection combined with small in-testinal bacterial overgrowth[J]. The Journal of Practical Medicine, 2024, 40(9): 1303-1308.
|
[9] |
江婧婧, 刘涵轩, 沈婉君, 等. 成年健康人群幽门螺旋杆菌感染检测结果分析及方法比较[J]. 标记免疫分析与临床, 2023, 30(5): 782-785, 816.
JIANG J J, LIU H X, SHENG W J, et al. An Analysis of Helicobacter Pylori Infection Detection Results in Healthy Adults and Comparison of Methods[J]. Labeled Immunoassays and Clinical Medicine, 2023, 30(5): 782-785, 816.
|
[10] |
SAXENA A, MUKHOPADHYAY A K, NANDI S P. Helicobacter pylori: perturbation and restoration of gut microbiome[J]. J Biosci, 2020, 45(1): 110.
|
[11] |
程艳萍, 张琰, 杨圣, 等. 胃癌家族史及血清学指标联合14C呼气试验在中老年人群胃癌筛查中价值[J]. 中国公共卫生, 2020, 36(1): 16-19.
CHENG Y P, ZHANG Y, YANG S, et al. Significance of stomach cancer family history and serological indicators combined with 14C-urea breath test in gastric cancer screening among middle-aged and elderly community residents[J]. Chinese Journal of Public Health, 2020, 36(1): 16-19.
|
[12] |
李继岩, 韩莹莹, 官佳轮, 等. 体检人群幽门螺杆菌感染检测意愿调查[J]. 胃肠病学和肝病学杂志, 2024, 33(5): 502-508.
LI J Y, HAN Y Y, GUAN J L, et al. Survey of willingness to detect Helicobacter pylori infection among physical exami-nation population[J]. Chinese Journal of Gastroenterology and Hepatology, 2024, 33(5): 502-508.
|
[13] |
REN S, CAI P, LIU Y, et al. Prevalence of Helicobacter pylori infection in China: a systematic review and meta-analysis[J]. J Gastroenterol Hepatol, 2022, 37(3): 464-470.
|
[14] |
汪俊虎, 朱盼盼, 刘芳芳, 等. 1 096例健康体检者幽门螺杆菌感染状况及其影响因素[J]. 中华健康管理学杂志, 2024, 18(3): 214-216.
WANG J H, ZHU P P, LIU F F, et al. Status of Helicobacter pylori infection and its influencing factors in 1 096 healthy subjects[J]. Chinese Journal of Health Management, 2024, 18(3): 214-216.
|
[15] |
王刚, 张振玉, 梅燕萍, 等. 南京地区体检人群幽门螺杆菌13C呼气试验与免疫分型结果分析[J]. 标记免疫分析与临床, 2023, 30(1): 57-60, 169.
WANG G, ZHANG Z Y, MEI Y P, et al. An Analysis of 13C Breath Test and Immunophenotyping Results of Helicobacter Pylori in Health Examination Population in Nanjing Area[J]. Labeled Immunoassays and Clinical Medicine, 2023, 30(1): 57-60, 169.
|
[16] |
吴正奇, 张志镒, 陶雪梅, 等. 甘肃省某医院14C呼气试验受检者幽门螺杆菌感染现状[J]. 兰州大学学报(医学版), 2022, 48(4): 56-58.
WU Z Q, ZHANG Z Y, TAO X M, et al. Helicobacter pylori infection in 14C breath test subjects in a hospital of Gansu Province[J]. Journal of Lanzhou University (Medical Sciences), 2022, 48(4): 56-58.
|
[17] |
刘学欣, 吴晓倩, 王晓曦, 等. 2023年河北省某医院体检者吸烟与幽门螺杆菌感染相关性分析[J]. 疾病监测, 2024, 39(7): 924-928.
LIU X X, WU X Q, WANG X X, et al. Analysis on correlation between smoking and Helicobacter pylori infection in subjects of a hospital in Hebei, 2023[J]. Disease Surveillance, 2024, 39(7): 924-928.
|
[18] |
王志芳, 曹伟, 杨小密, 等. 新疆喀什地区体检人群幽门螺杆菌感染现状及相关因素分析[J]. 临床内科杂志, 2024, 41(8): 550-553.
WANG Z F, CAO W, YANG X M, et al. Analysis of Helicobacter pylori infection status and related factors in physical examination population in Kashgar, Xinjiang[J]. Journal of Clinical Internal Medicine, 2024, 41(8): 550-553.
|
[19] |
巴德文毛, 张秋梅, 永措, 等. 玉树地区藏族人群幽门螺杆菌感染临床特点和相关性分析: 1项队列研究[J]. 胃肠病学和肝病学杂志, 2024, 33(11): 1430-1433.
BA D W M, ZHANG Q M, YONG C, et al. Clinical characteristics and correlation analysis of Helicobacter pylori infection in Tibetan population in Yushu area: one cohort study[J]. Chinese Journal of Gastroenterology and Hepatology, 2024, 33(11): 1430-1433.
|
[20] |
LI Y, CHOI H, LEUNG K, et al. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis[J]. Lancet Gastroenterol Hepatol, 2023, 8(6): 553-564.
|
[21] |
狄佳, 吴涛, 吴金鑫, 等. 陕西农村地区儿童幽门螺杆菌感染的危险因素调查及与慢性肠系膜淋巴结炎的相关性研究[J]. 中国中西医结合消化杂志, 2024, 32(6): 518-525.
DI J, WU T, WU J X, et al. Investigation on risk factors of Helicobacter pylori infection in children in rural areas of Shaanxi Province and its correlation with chronic mesenteric lymphadenitis[J]. Chinese Journal of Integrated Traditional and Western Medicine on Digestion, 2024, 32(6): 518-525.
|
[22] |
曾凡, 张大涯, 陈世锔, 等. 海南省五指山市人群幽门螺旋杆菌感染现状调查及相关危险因素分析[J]. 现代消化及介入诊疗, 2023, 28(8): 957-961.
ZENG F, ZHANG D Y, CHEN S J, et al. Investigation on the current status of Helicobacter pylori infection and analysis of related risk factors in the population of Wuzhishan City[J]. Modern Digestion & Intervention, 2023, 28(8): 957-961.
|
[23] |
武红梅, 赵晓丽. 体检人群幽门螺杆菌感染的危险因素及其与血清PGⅠ、PGⅡ、G-17的相关性[J]. 中国医药导报, 2024, 21(8): 78-81.
WU H M, ZHAO X L. Risk factors of Helicobacter pylori infection and its correlation with serum PGⅠ, PGⅡ, and G-17[J]. China Medical Herald, 2024, 21(8): 78-81.
|
[24] |
杨密, 董洁, 王玘, 等. 北京地区健康体检者幽门螺杆菌感染情况及其毒力因子特征分析[J]. 华南预防医学, 2024, 50(2): 128-132.
YANG M, DONG J, WANG Q, et al. Analysis of Helicobacter pylori infection and its virulence factors in healthy people in Beijing[J]. South China Journal of Preventive Medicine, 2024, 50(2): 128-132.
|